XML 60 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaborative Agreements (Details) - Collaborative Arrangement, Product [Member]
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 28, 2016
Aug. 07, 2015
USD ($)
product
Nov. 14, 2014
Apr. 30, 2015
USD ($)
Sep. 30, 2013
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received         $ 10,000,000        
INO-3112 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized   $ 15,000,000              
License To Research Collaboration Products [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions   12,500,000              
INO 5150 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized         5,000,000        
INO 1800 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized         3,400,000        
Option Right [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions         1,500,000        
Joint Steering Committee Obligation [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions         155,000        
MedImmune [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received   27,500,000              
Anticipated development and regulatory event based payment receivable milestones   $ 700,000,000              
Number of additional products to be developed | product   2              
Revenue under collaborative research and development arrangements           $ 307,000   $ 697,000  
Deferred revenue           13,300,000   13,300,000  
Accounts receivable           886,000   886,000  
Hoffman-La Roche [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received         10,000,000        
Anticipated development and regulatory event based payment receivable milestones         $ 3,000,000        
Revenue under collaborative research and development arrangements                 $ 3,000,000
Deferred revenue           130,000   130,000  
Accounts receivable           4,000,000   4,000,000  
Length of period after date of product first commercial sale to determine agreement in effect terms         10 years        
Previously deferred revenue recognized           1,600,000 $ 4,300,000 3,000,000 8,600,000
Hoffman-La Roche [Member] | INO 5150 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Days subsequent to termination notice effective     90 days            
Defense Advanced Research Projects Agency (DARPA) [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue           1,300,000   1,300,000  
Accounts receivable           5,000,000   5,000,000  
Term       2 years          
Base award       $ 19,600,000          
Option award       24,600,000          
Second option award       $ 11,100,000          
Previously deferred revenue recognized           $ 3,700,000 $ 0 $ 8,200,000 $ 0
Subsequent Event [Member] | Hoffman-La Roche [Member] | INO 1800 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Days subsequent to termination notice effective 90 days